| 1579 |
Rehabilitation service to TB patients |
14/04/2022 |
|
| 1580 |
Socio economic factors affecting TB patients |
14/04/2022 |
|
| 512 |
Drug Sensitive Tuberculosis [DS-TB] |
15/04/2022 |
|
| 1593 |
Role of LSG in TB Elimination |
15/04/2022 |
|
| 862 |
PPSA |
15/04/2022 |
|
| 1603 |
Joint Effort for Elimination of Tuberculosis [JEET] Model of the Patient Provider Support Agency [PPSA] |
15/04/2022 |
|
| 1608 |
IEC material for general public |
15/04/2022 |
|
| 1611 |
IEC strategies for CHVs |
15/04/2022 |
|
| 1612 |
Peer group interventions |
15/04/2022 |
|
| 1623 |
Target Audience for ACSM activities |
15/04/2022 |
|
| 1632 |
Supervision by STS |
15/04/2022 |
|
| 1681 |
Internal Evaluation |
17/04/2022 |
|
| 1689 |
Semiquantitative Results Interpretation in CBNAAT |
17/04/2022 |
|
| 1693 |
Hardware Problems with the CBNAAT Machine |
17/04/2022 |
|
| 1692 |
MTB Detected-Rif Indeterminate Results Interpretation in CBNAAT |
17/04/2022 |
|
| 1705 |
TB Laboratory Design and Facilities as a Biosafety Measure |
17/04/2022 |
|
| 1707 |
Ventilation in TB Laboratories as a Biosafety Measure |
17/04/2022 |
|
| 32 |
Infection Prevention and Control [IPC] |
17/04/2022 |
|
| 1710 |
Low-risk TB Laboratories |
17/04/2022 |
|
| 1711 |
Emergency Preparedness Plan in TB Lab Settings |
17/04/2022 |
|
| 1712 |
TB Laboratory Accidents Leading to Infectious Spillage |
17/04/2022 |
|
| 1713 |
Fire Safety in TB Lab Settings |
17/04/2022 |
|
| 1722 |
Self-contained CBNAAT Cartridge |
17/04/2022 |
|
| 1724 |
Monitoring of Treatment by Smear and Culture |
17/04/2022 |
|
| 1727 |
Quality Control of MGIT 960 Tubes |
17/04/2022 |
|
| 1726 |
MGIT 960 Instrument: Operation |
17/04/2022 |
|
| 1730 |
Reporting First-line Line Probe Assay [FL-LPA] Results |
18/04/2022 |
|
| 1731 |
Reporting Second Line-Line Probe Assay [SL-LPA] Results |
18/04/2022 |
|
| 1738 |
How to Use Refrigerated Centrifuges |
18/04/2022 |
|
| 1750 |
Steps to be done after Culture Specimen Processing |
18/04/2022 |
|
